Rapamycin Impurities & Reference Standards

Invenza supplies high-quality Rapamycin Reference Standards, Rapamycin impurities, pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope-labeled compounds, and nitrosamine-related products for pharmaceutical research, analytical testing, and quality control applications.

Our Rapamycin impurity reference standards are suitable for a wide range of pharmaceutical and analytical applications, including drug development, analytical method development and validation, quality control (QC), stability studies, impurity profiling, unknown impurity identification, regulatory submissions such as ANDA and DMF, and assessment of potential genotoxic impurities.

Rapamycin-related reference standards are thoroughly characterized and supplied with Certificates of Analysis (COA) and supporting analytical data, subject to product availability and applicable specifications. We can also provide pharmacopeial and traceable reference standards, including EP/USP-related requirements, based on customer specifications

Our Rapamycin impurity standards are manufactured, characterized, and handled to support reliable analytical testing and pharmaceutical research requirements. Products are periodically re-tested, where applicable, to help ensure consistent quality and dependable analytical performance.

CAT No. IR-A18081
CAS No. 53123-88-9
Molecular Formula C51H79NO13
Molecular Weight 914.17
CAT No. IR-A18082
CAS No. 253431-35-5
Molecular Formula C51H79NO13
Molecular Weight 914.17
CAT No. IR-A18083
CAS No. 151519-50-5
Molecular Formula C50H77NO13
Molecular Weight 900.15
CAT No. IR-A18084
CAS No. 500733-49-3
Molecular Formula C51H79NO15
Molecular Weight 946.2